Vacuolar myelopathy: a case report of functional, clinical, and radiological improvement after highly active antiretroviral therapy

Di Rocca, 2003, HIV associated myelopathy, Curr Treat Options Infect Dis, 5, 457

Petito, 1985, Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome, N Engl J Med, 312, 874, 10.1056/NEJM198504043121402

Dal Pan, 1994, Clinicopathologic correlations of HIV associated vacuolar myelopathy: an autopsy based case–control study, Neurology, 44, 2159, 10.1212/WNL.44.11.2159

Fernandez-Fernandez, 2004, Remission of HIV-associated myelopathy after highly active antiretroviral therapy, J Postgrad Med, 50, 195

McArthur, 2005, Neurological complications of HIV Infection, Lancet Neurol, 4, 543, 10.1016/S1474-4422(05)70165-4

Singh NN, Thomas FP. HIV-1 associated vacuolar myelopathy. eMedicine-WebMD. March 2007. Available at: http://www.emedicine.com/NEURO/topic449.htm (accessed November 2007).

Hepburn, 2004, Low serum vitamin B12 levels in an outpatient HIV-infected population, Int J STD AIDS, 15, 127, 10.1258/095646204322764334

Remacha, 2003, Vitamin B12 metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B12 stores, Am J Clin Nutr, 77, 420, 10.1093/ajcn/77.2.420

Swagel E. The elusive (and maybe non-existent) connection between vitamin B12 and HIV. Nutrition Bytes 1996; 2:Article 4. Available at: http://repositories.cdlib.org/uclabiolchem/nutritionbytes/vol2/iss2/art4 (accessed November 2007).

Nagaishi, 2003, [A case of subacute combined degeneration with normal serum vitamin B12 level] (in Japanese), Rinsho Shinkeigaku, 43, 552